¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"immune response suppression"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response
¸é¿ª¹ÝÀÀ
immune response gene
¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
memory immune response
¸é¿ª±â¾ï¹ÝÀÀ
primary immune response
ÀÏÂ÷¸é¿ª¹ÝÀÀ
secondary immune response
ÀÌÂ÷¸é¿ª¹ÝÀÀ
burst-suppression
µ¹¹ßÆÄ¾ïÁ¦
frequency selective fat suppression technique
Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
motion artifact suppression technique
¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
suppression
1. ¾ïÁ¦, ¾ï¾Ð 2. Á¦°Å 3. ÁøÈ
suppression amblyopia
¾ïÁ¦¾à½Ã
suppression scotoma
¾ïÁ¦¾ÏÁ¡
water suppression
¹°ºÐÀÚ¾ïÁ¦
acquired immune deficiency syndrome
ÈÄõ¸é¿ª°áÇÌÁõÈıº, ¿¡ÀÌÁî
circulating immune complex
¼øÈ¯¸é¿ªº¹ÇÕü
drug-induced immune complex
¾à¹°À¯¹ß¸é¿ªº¹ÇÕü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
13
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune thrombocytopenic purpura
¸é¿ªÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ý
suppression
¾ïÁ¦
response curve
¹ÝÀÀ°î¼±
response decline
¹ÝÀÀ°¨¼Ò
response
¹ÝÀÀ
autoimmune response
ÀÚ°¡¸é¿ª¹ÝÀÀ
dose-response relationship
¿ë·®¹ÝÀÀ°ü°è
inflammatory response
¿°Áõ¹ÝÀÀ
late asthmatic response
¸¸±âõ½Ä¹ÝÀÀ, Èıâõ½Ä¹ÝÀÀ
response rate
¹ÝÀÀ·ü
startle response
³î¶÷¹ÝÀÀ
withdrawal response
±Ý´Ü¹ÝÀÀ
systemic inflammatory response syndrome
Àü½Å¿°Áõ¹ÝÀÀÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response suppression
¸é¿ª¹ÝÀÀ¾ïÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response gene
¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
immune response
¸é¿ª¹ÝÀÀ
memory immune response
¸é¿ª±â¾ï¹ÝÀÀ
primary immune response
ÀÏÂ÷¸é¿ª¹ÝÀÀ
secondary immune response
ÀÌÂ÷¸é¿ª¹ÝÀÀ
soluble immune response suppressor
°¡¿ë¸é¿ª¹ÝÀÀ¾ïÁ¦ÀÎÀÚ
suppression amblyopia
¾ïÁ¦¾à½Ã
burst-suppression
µ¹¹ßÆÄ¾ïÁ¦
central suppression
Á߽ɾïÁ¦
frequency selective fat suppression technique
Á֯ļö¼±ÅÃÁö¹æ¾ïÁ¦±â¹ý
magnetization transfer suppression
ÀÚ±âÈÀü´Þ¾ïÁ¦
motion artifact suppression technique
¿îµ¿ÀΰøÀ½¿µ¾ïÁ¦¼ú
suppression mutation
¾ïÁ¦µ¹¿¬º¯ÀÌ
obligatory suppression
ºÒº¯¾ïÁ¦
suppression
¾ïÁ¦
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response suppression
¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response
¸é¿ªÀÀ´ä.
immune response
¸é¿ª¹ÝÀÀ
immune response
¸é¿ªÀÀ´ä.
immune response
¸é¿ªÀÀ´ä.
immune response gene
¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ.
immune response gene
¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
immune response, primary
ÀÏÂ÷¸é¿ª¹ÝÀÀ
immune response, secondary
ÀÌÂ÷¸é¿ª¹ÝÀÀ
primary immune response
ÀÏÂ÷¸é¿ª¹ÝÀÀ(¡Øóæ¹Úãëë).
primary immune response
ÀÏÂ÷¸é¿ª¹ÝÀÀ(¡Øóæ¹Úãëë).
anti-suppression exercise
¾ïÁ¦¹æÁöÈÆ·Ã
frequency selective fat suppression technique
Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
glucocorticoid suppression test
´çÁúÄÚ¸£Æ¼ÄÚÀ̵å¾ïÁ¦½ÃÇè.
phase evolution of fat suppression
À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
phenotypic suppression
Ç¥ÇöÇü ¾ïÁ¦
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response suppression
¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
immune response
¸é¿ª¹ÝÀÀ
immune response
¸é¿ªÀÀ´ä.
immune response
¸é¿ªÀÀ´ä.
immune response
¸é¿ªÀÀ´ä.
immune response gene
¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
immune response gene
¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ.
immune response, primary
ÀÏÂ÷¸é¿ª¹ÝÀÀ
immune response, secondary
ÀÌÂ÷¸é¿ª¹ÝÀÀ
memory immune response
¸é¿ªÇÐÀû±â¾ï¹ÝÀÀ
primary immune response
ÀÏÂ÷¸é¿ª¹ÝÀÀ(¡Øóæ¹Úãëë).
primary immune response
ÀÏÂ÷¸é¿ª¹ÝÀÀ(¡Øóæ¹Úãëë).
secondary immune response
ÀÌÂ÷Àû ¸é¿ª¹ÝÀÀ(ì£óîÜØóæ¹Úãëë).
secondary immune response
ÀÌÂ÷Àû ¸é¿ª¹ÝÀÀ(ì£óîÜØóæ¹Úãëë).
soluble immune response suppressor
°¡¿ë¼º ¸é¿ª¹ÝÀÀ¾ïÁ¦ÀÎÀÚ
anti-suppression exercise
¾ïÁ¦¹æÁöÈÆ·Ã
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½